| II-05 Andrzej Bienczak Application of model informed drug development to pediatric program for ligelizumab in Chronic Spontaneous Urticaria Wednesday 15:10-16:40 |
| II-05 Andrzej Bienczak Application of model informed drug development to pediatric program for ligelizumab in Chronic Spontaneous Urticaria Wednesday 15:10-16:40 |